Search Results - Chenjing Wang

Retraction Note: Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p/PAPD5 by Chenjing Wang, Jin Zhao, Xiaodong Nan, Zhong Guo, Shuangsheng Huang, Xiaokun Wang, Feng Sun, Shijie Ma

Connect to this object online.

Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p/PAPD5 by Chenjing Wang, Jin Zhao, Xiaodong Nan, Zhong Guo, Shuangsheng Huang, Xiaokun Wang, Feng Sun, Shijie Ma

Connect to this object online.

Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study by Xin Li, Chenjing Wang, Ting Li, Yanping Liu, Shuqin Liu, Ye Tao, Yaping Ma, Xiaomeng Gao, Yu Cao

Connect to this object online.

Neuroprotective effect of acetoxypachydiol against oxidative stress through activation of the Keap1-Nrf2/HO-1 pathway by Yu Qi, Ge Liu, Shengjie Jin, Rong Jian, Ziqiang Zou, Chenjing Wang, Yuanlong Zhang, Min Zhao, Haoru Zhu, Pengcheng Yan

Connect to this object online.

Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects by Feifei Sun, Yanping Liu, Ting Li, Pingping Lin, Xin Jiang, Xin Li, Chenjing Wang, Xiaomeng Gao, Yaping Ma, Yao Fu, Yu Cao

Connect to this object online.

Tolerability, safety, and pharmacokinetics of a single intravenous administration of a novel recombinant humanized anti-interleukin-6 receptor monoclonal antibody in healthy Chines... by Xin Jiang, Pingping Lin, Feifei Sun, Yi Xu, Ye Tao, Ping Shi, Yanping Liu, Xin Li, Shuqin Liu, Xiaomeng Gao, Chenjing Wang, Yu Cao

Connect to this object online.

Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects by Xin Li, Chenjing Wang, Ping Shi, Yanping Liu, Ye Tao, Pingping Lin, Ting Li, Haixun Hu, Feifei Sun, Shuqin Liu, Yao Fu, Yu Cao

Connect to this object online.

Jin-Zhen oral liquid for pediatric coronavirus disease (COVID-19): A randomly controlled, open-label, and non-inferiority trial at multiple clinical centers by Qian Dong, Hongmei Qiao, Huiyi Jiang, Lixiao Liu, Yanling Ge, Fang-Jiao Zong, Yanan Li, Bingzi Dong, Sujuan Hu, Dongmei Meng, Rong Jin, Xiangshi Wang, Hailing Chang, Xiaolong Xu, Chenjing Wang, Yu Cao, Han-Ting Zhang, Qingquan Liu

Connect to this object online.